A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults

Completed · Phase 3

Conditions studied: Rhinitis, Allergic, Perennial

In brief

The purpose of this study is to assess the effect of an aqueous nasal spray investigational compound compared to placebo on the hypothalamic pituitary adrenocortical (HPA) axis system in adolescents and adults 12 to 65 years of age with perennial allergic rhinitis. This study can last up to 6 weeks and you will come to the clinic up to 7 times. Clinic visits include physical examinations, vital sign assessments, clinical laboratory assessments, ECGs and allergy skin testing. You will need to complete a daily diary card and spend the night in the clinic on 2 occasions to collect urine and blood samples over 24 hour periods.

Key facts

Study ID

NCT00116818

Run by

GlaxoSmithKline

People needed

90

Starts

2005-01-01

Expected to finish

2005-05-01

Last updated by the study team

2016-09-15

Who can join

Age: 12 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis and history of perennial allergic rhinitis.
• Must be willing to stay overnight in the clinic at the beginning and end of the study for the collection of urine and blood samples over 24 hours.
• Must comply with all study procedures and be literate.

You may not qualify if…

• Use of tobacco products.
• Work a rotating shift.
• Significant concurrent medical conditions.
• Certain medications such as corticosteroids and allergy medications.

Where it is running

• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Mississauga, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.